Published in BMC Microbiol on June 23, 2010
Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin. Antimicrob Agents Chemother (2012) 1.01
Effective control of Salmonella infections by employing combinations of recombinant antimicrobial human β-defensins hBD-1 and hBD-2. Antimicrob Agents Chemother (2014) 0.84
Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob Agents Chemother (2012) 0.83
Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome. Nucleic Acids Res (2016) 0.82
Influence of the yjiL-mdtM Gene Cluster on the Antibacterial Activity of Proline-Rich Antimicrobial Peptides Overcoming Escherichia coli Resistance Induced by the Missing SbmA Transporter System. Antimicrob Agents Chemother (2015) 0.81
In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validation. Int J Mol Imaging (2013) 0.81
N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa. Front Cell Dev Biol (2016) 0.80
In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs. Front Chem (2017) 0.75
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 10.15
Mode of action of membrane active antimicrobial peptides. Biopolymers (2002) 4.74
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect (2001) 3.12
Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol (2006) 2.95
The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol (2005) 1.94
Fluorescence lifetime imaging system for in vivo studies. Mol Imaging (2007) 1.83
A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci (2005) 1.78
Role of the high-affinity zinc uptake znuABC system in Salmonella enterica serovar typhimurium virulence. Infect Immun (2002) 1.44
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol Microbiol (2007) 1.38
The short proline-rich antibacterial peptide family. Cell Mol Life Sci (2002) 1.29
Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J Leukoc Biol (2004) 1.28
Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry (2002) 1.23
Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr Pharm Des (2002) 1.16
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides (2007) 1.16
Dual mode of action of Bac7, a proline-rich antibacterial peptide. Biochim Biophys Acta (2006) 1.12
Essential role for the BacA protein in the uptake of a truncated eukaryotic peptide in Sinorhizobium meliloti. J Bacteriol (2008) 1.11
In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides (2003) 1.04
Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Peptides (2004) 1.01
Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J Biol Chem (2005) 0.96
Ciprofloxacin treatment of systemic salmonella infection in sensitive and resistance mice. J Antimicrob Chemother (1985) 0.92
Artificial beta-defensin based on a minimal defensin template. Biochem J (2009) 0.90
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide. Shock (2003) 0.86
Peptide antibiotics: an alternative and effective antimicrobial strategy to circumvent fungal infections. Peptides (2009) 0.85
The effect of different doses of cisplatin on the pharmacokinetic parameters of cefepime in mice. Lab Anim (2006) 0.84
Molecular cloning of Bac7, a proline- and arginine-rich antimicrobial peptide from bovine neutrophils. FEBS Lett (1994) 0.81
Comparison of host responses induced by Salmonella typhimurium infection in genetically resistant and susceptible mice. J Med Microbiol (1990) 0.77
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. Arthritis Rheum (2012) 1.61
Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl (2005) 1.55
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol Microbiol (2007) 1.38
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother (2006) 1.24
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. Cancer Res (2007) 1.21
Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell Mol Life Sci (2011) 1.20
Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. Biomacromolecules (2009) 1.18
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One (2010) 1.16
Dual mode of action of Bac7, a proline-rich antibacterial peptide. Biochim Biophys Acta (2006) 1.12
Essential role for the BacA protein in the uptake of a truncated eukaryotic peptide in Sinorhizobium meliloti. J Bacteriol (2008) 1.11
BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol (2002) 1.08
In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions. Blood (2011) 1.06
In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides (2003) 1.04
Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Peptides (2004) 1.01
Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr Pharm Des (2002) 0.97
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity. Int J Oncol (2002) 0.95
BacA is essential for bacteroid development in nodules of galegoid, but not phaseoloid, legumes. J Bacteriol (2010) 0.94
Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. Nanoscale (2010) 0.94
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. Mol Imaging (2009) 0.94
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice. Nucleic Acids Res (2013) 0.94
Rapid and reliable detection of antimicrobial peptide penetration into gram-negative bacteria based on fluorescence quenching. Antimicrob Agents Chemother (2009) 0.93
Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen. Clin Cancer Res (2003) 0.93
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. BMC Microbiol (2012) 0.92
Structural and functional characterization of hBD-1(Ser35), a peptide deduced from a DEFB1 polymorphism. Biochem Biophys Res Commun (2002) 0.92
Functional characterization of SbmA, a bacterial inner membrane transporter required for importing the antimicrobial peptide Bac7(1-35). J Bacteriol (2013) 0.92
Internalization of a thiazole-modified peptide in Sinorhizobium meliloti occurs by BacA-dependent and -independent mechanisms. Microbiology (2010) 0.92
Antimicrobial peptides: synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues. J Med Chem (2002) 0.91
Dendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse model. PLoS One (2013) 0.91
Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J (2005) 0.90
C1q as a unique player in angiogenesis with therapeutic implication in wound healing. Proc Natl Acad Sci U S A (2014) 0.89
Activity of cathelicidin peptides against Chlamydia spp. Antimicrob Agents Chemother (2005) 0.89
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. Clin Cancer Res (2004) 0.89
Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother (2002) 0.88
Structural aspects of plant antimicrobial peptides. Curr Protein Pept Sci (2010) 0.88
Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7. J Med Chem (2015) 0.88
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. Curr Pharm Des (2008) 0.88
Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region. PLoS One (2013) 0.87
Functional and structural study of the dimeric inner membrane protein SbmA. J Bacteriol (2013) 0.87
Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment. Mol Immunol (2010) 0.87
Investigating the mode of action of proline-rich antimicrobial peptides using a genetic approach: a tool to identify new bacterial targets amenable to the design of novel antibiotics. Methods Mol Biol (2008) 0.86
Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia. J Antimicrob Chemother (2003) 0.85
Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides (2005) 0.85
Sensitivity of Chlamydia suis to cathelicidin peptides. Vet Microbiol (2007) 0.85
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles. PLoS One (2013) 0.85
Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J Leukoc Biol (2002) 0.84
Antifungal activity of amphotericin B conjugated to carbon nanotubes. ACS Nano (2010) 0.84
In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides (2004) 0.83
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies. Eur J Immunol (2002) 0.82
Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: a preclinical study. Invest New Drugs (2004) 0.82
Nitric oxide-mediated activity in anti-cancer photodynamic therapy. Nitric Oxide (2013) 0.81
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. Curr Clin Pharmacol (2010) 0.81
Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes. Nutr Neurosci (2009) 0.81
Polyol synthesis of silver nanoparticles: mechanism of reduction by alditol bearing polysaccharides. Biomacromolecules (2009) 0.81
Design, synthesis and antimicrobial properties of non-hemolytic cationic alpha-cyclopeptoids. Bioorg Med Chem (2010) 0.81
In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validation. Int J Mol Imaging (2013) 0.81
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq. Toxicology (2013) 0.81
The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice. Invest New Drugs (2012) 0.80
Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation. J Med Chem (2009) 0.80
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies. Mol Cancer (2014) 0.80
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. J Hematol Oncol (2014) 0.80
Protein supplementation may enhance the spontaneous recovery of neurological alterations in patients with ischaemic stroke. Clin Rehabil (2008) 0.80
The salmonid cathelicidins: a gene family with highly varied C-terminal antimicrobial domains. Comp Biochem Physiol B Biochem Mol Biol (2009) 0.78
Proteolytic activity of Escherichia coli oligopeptidase B against proline-rich antimicrobial peptides. J Microbiol Biotechnol (2014) 0.78
Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide. Antimicrob Agents Chemother (2004) 0.78
The one-step synthesis and surface functionalization of dumbbell-like gold-iron oxide nanoparticles: a chitosan-based nanotheranostic system. Chem Commun (Camb) (2015) 0.77
Enteric YaiW is a surface-exposed outer membrane lipoprotein that affects sensitivity to an antimicrobial peptide. J Bacteriol (2013) 0.77
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A. Metallomics (2015) 0.77
Cubosomes for in vivo fluorescence lifetime imaging. Nanotechnology (2016) 0.77
Conjugated PDT drug: photosensitizing activity and tissue distribution of PEGylated pheophorbide a. Cancer Biol Ther (2010) 0.77
Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report. Pancreas (2008) 0.77
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment. J Pharmacol Exp Ther (2004) 0.77
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. Int J Oncol (2004) 0.76
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice. J Inorg Biochem (2012) 0.76
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: an in vitro study. Eur J Ophthalmol (2011) 0.76
Increasing effect of a high dose of PG-1 peptide on the infectivity of Chlamydophila abortus. FEMS Immunol Med Microbiol (2010) 0.76
Effect of calorie-protein supplementation on the cognitive recovery of patients with subacute stroke. Nutr Neurosci (2008) 0.76
Use of unnatural amino acids to probe structure-activity relationships and mode-of-action of antimicrobial peptides. Methods Mol Biol (2012) 0.76
Cellular internalization and cytotoxicity of the antimicrobial proline-rich peptide Bac7(1-35) in monocytes/macrophages, and its activity against phagocytosed Salmonella typhimurium. Protein Pept Lett (2014) 0.76